688520.SH
神州细胞
SSE · Healthcare · Biotechnology · CN
CNY 36.39
−3.96%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 1151.00x
- P/S forward
- 44.03x
Trailing multiples
Trailing twelve months
- P/E TTM
- -30.30x
- PEG TTM
- —
- Price / book
- 241.66x
- Price / sales
- 11.91x
- Price / cash flow
- -62.09x
Enterprise value
- Enterprise value
- CNY 17.4B
- EV / sales
- 12.76x
- EV / EBITDA
- -65.17x
- EV / EBIT
- -28.18x
- Market cap
- CNY 17.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026